BIOMAT Database Logo BIOMAT Database Logo

Pyribenzamine (N-pyridyl, N-benzyl, dimethyl-ethylenedia-minehydrochloride) in the treatment of allergy. 1947

A T HENDERSON, and B ROSE

UI MeSH Term Description Entries
D006967 Hypersensitivity Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen. Allergy,Allergic Reaction,Allergic Reactions,Allergies,Hypersensitivities,Reaction, Allergic,Reactions, Allergic
D007154 Immune System Diseases Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both. Immune Disorders,Immune System Disorders,Immunologic Diseases,Diseases of Immune System,Immune Diseases,Immunological Diseases,Disease, Immune,Disease, Immune System,Disease, Immunologic,Disease, Immunological,Disorder, Immune System,Immune Disease,Immune Disorder,Immune System Disease,Immune System Disorder,Immunologic Disease,Immunological Disease
D000707 Anaphylaxis An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death. Anaphylactic Reaction,Anaphylactoid Reaction,Anaphylactoid Shock,Shock, Anaphylactic,Anaphylactic Reactions,Anaphylactic Shock,Anaphylactoid Reactions,Reaction, Anaphylactic,Reaction, Anaphylactoid,Shock, Anaphylactoid
D014309 Tripelennamine A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically. Azaron,Histantin,Pyribenzamine,Tripelennamine Citrate,Tripelennamine Citrate (1:1),Tripelennamine Hydrochloride,Tripelennamine Maleate,Tripelennamine Maleate (1:1),Tripelennamine Monohydrochloride,Vetibenzamin

Related Publications

A T HENDERSON, and B ROSE
Pharmacodynamic studies of a new antihistaminic agent, pyribenzamine (N,N-dimethyl-N'-benzyl-N'-(alpha-pyridyl)-ethylene diamine hydrochloride).
January 1947, The Journal of pharmacology and experimental therapeutics,
A T HENDERSON, and B ROSE
The effect of reduced caloric intake on the toxicity of N,N-dimethyl-N'-benzyl-N'-(alpha-pyridyl)-ethylenediamine monohydrochloride (pyribenzamine).
January 1947, Federation proceedings,
A T HENDERSON, and B ROSE
Pyribenzamine (n'-pyridyl-n'-benzyl-n-dimethylethylenediamine HC1), an antagonist of histamine.
July 1946, The Journal of laboratory and clinical medicine,
A T HENDERSON, and B ROSE
Adrenergic potentiation by pyribenzamine HCl (N-pyridyl N-benzyl-N-dimethylethylenediamine HCl).
January 1946, Federation proceedings,
A T HENDERSON, and B ROSE
The symptomatic treatment of hay fever with diaminobenzopyridyl HCl (N'-pyridyl-N'-benzyl-N-dimethylethylenediamine hydrochloride)(pyribenzamine).
May 1947, New York state journal of medicine,
A T HENDERSON, and B ROSE
[The influence of pyribenzamine (benzyl-alpha-pyridyl-dimethyl-ethylene-diamine) on the blood sugar level].
January 1952, Biochemische Zeitschrift,
A T HENDERSON, and B ROSE
Acute and chronic toxicity studies of pyribenzamine hydrochloride (N-pyridyl-N-benzyl-N-dimethylethylene diamine HCl.
January 1946, Federation proceedings,
A T HENDERSON, and B ROSE
Antihistamine agents; halogenated N,N-dimethyl-N-benzyl-N-(2-pyridyl)-ethylenediamines.
March 1949, The Journal of organic chemistry,
A T HENDERSON, and B ROSE
Histamine antagonists; pyridil-N'benzyl-N-dimethyl-ethylenediamine (pyribenzamine) in symptomatic treatment of allergic manifestations.
January 1947, The American journal of the medical sciences,
A T HENDERSON, and B ROSE
Antihistamine salts of penicillin. II. Preparation and properties of the penicillin G salt of N,N-dimethyl-N'-benzyl-N'-(alpha-pyridyl) ethylenediamine.
November 1954, Antibiotics & chemotherapy (Northfield, Ill.),
Copied contents to your clipboard!